Insider trade

Director sold ~$220K of HQY shares in the open market

Traded May 28, 2026 · Filed Jun 1, 2026

Why it stands out

A board member of HealthEquity sold $220K of HealthEquity shares. It was planned long ago, so it says very little.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Director$100K–$500KPre-arranged plan referenced

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$219,510

Shares × reported transaction price

Timing vs results

on the day of results (May 28, 2026), 91 days before results of Aug 27, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Planned / mechanical clue

Footnote references a pre-arranged trading plan (Rule 10b5-1)

Only flagged when a footnote says so; never inferred

After	Stock	S&P 500	Difference
7 days	+1.0%	−3.0%	+4.0%
30 days	+7.9%	−1.9%	+9.8%
90 days	+9.3%	+1.0%	+8.3%

Past results only. Not a forecast.

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 14, 2026.

3mo ago

Compensation award — excluded from discretionary-purchase analysis.

3mo ago

Compensation award — excluded from discretionary-purchase analysis.

3mo ago

Compensation award — excluded from discretionary-purchase analysis.